CClinicalTrials.gg
RecruitingNCT06467929Updated Sep 19, 2024

Prospective Collection of Endoscopic and Histopathologic Data from Endoscopic Procedures Performed in UZ Gent

An observational study in Endoscopy, sponsored by University Hospital, Ghent. Recruiting at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-09-19.

Sponsored by University Hospital, Ghent · Observational

From the registry’s dates

  • Primary completion was expected by Oct 2025, 11 months ago, but the record still lists the study as recruiting.
  • Started Dec 2022; still recruiting 3 years 9 months later.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
510
Ages
18 Years and older
Sex
All
01

Study summary

This is an observational study in which images (photos and/or videos of lesions found during endoscopy) will be collected and the associated data about these lesions (size, location in the body, outcome of histology, if resected and examined).

The images will be taken while performing a diagnostic or therapeutic endoscopy. This footage can be recorded in different light modalities, and various lesions can be removed during one procedure. It is of importance that the images are recorded in the best possible image quality.

The images can be either endoscopic images or endoscopic images combined with room view (this means that the endoscopic room can be filmed, for example, to visualize the endoscopist and thus show techniques of the procedure, without the patient being identified). The GDPR regulations will be respected at all times during the video recordings.

The purpose of this registry is to create a database with images in the form of photos and video clips, histopathological data, demographic data of patients and data about the endoscopic procedure. The recording of this data is standard with every endoscopic procedure that patients undergo at UZ Gent.

The data will be used for the following purposes: linking procedural outcomes with procedural data and patient data to improve endoscopic technique and to guarantee quality in our endoscopic unit. In this way the investigators will also be able to identify trends and link adverse events back to the patient data with the aim of informing the patient. In addition, as a university center, the investigators can train doctors in training with this educational material. The footage can be shared via online and/or live presentations that are only accessible to/by healthcare workers and without the patient being identifiable. Such material and its dissemination is essential to improve (the safety of) techniques (such as those of today), to share knowledge about techniques, and in this way to train the next generation of doctors and nurses.

Read the detailed description

Background Endoscopy and more specifically polypectomy during endoscopy is well established as an effective way of reducing cancer mortality. The majority of lesions detected and removed at colonoscopy are adenomas \<10mm in size without advanced histology. These lesions have a low risk of progression to malignancy and are relatively easily removed by standard snare polypectomy with low complication rates. Polyps that are sessile or flat and greater than 20mm in size are found in approximately 1% of all colonoscopies and are more difficult to manage. These lesions, known as large sessile lesions (LSL), have a high rate of advanced histology. Traditionally they have been managed by referral for open or laparoscopic surgery, which is definitive, but invasive, costly, and associated with a significant mortality risk in patients with advanced age or comorbidities. Endoscopic Mucosal Resection (EMR) has emerged in recent years as an alternative to surgery that is now becoming the standard of care. It is an outpatient procedure which is effective, safe and less costly than surgery when delivered at a tertiary referral centre.

Prospective studies have been successful in addressing several aspects of the resection of LSL, producing robust information on the efficacy of the procedure, recurrence rates, bleeding complications and mortality and costs when compared to surgery. Assessment and management strategies for bleeding and deep mural injury or perforation have been derived from analysis of the data. Snare tip soft coagulation of the resection margin post-EMR has been shown to reduce recurrence in a randomised controlled trial.

There remain a number of unanswered questions regarding the endoscopic resection of large lesions and a new study incorporating a greater number of endoscopy units around the world will allow these to be addressed as well as answer questions on the clinical effectiveness of the technique. Enhancing the prediction of submucosal invasive cancer, advanced lesion classification, validation of the assessment of deep injury, treatment of lesion margins post resection to reduce recurrence, prevention and prophylaxis of bleeding, and subtype analyses of the different histological groups of colonic lesions will be examined.

In addition, other techniques such as endoscopic submucosal dissection (ESD) and full thickness resection (FTR) have emerged in recent years and require assessment of their performance versus endoscopic mucosal resection in prospective observational studies.

The same techniques (EMR and ESD) are used to resect lesions in the upper gastrointestinal tract (oesophagus, stomach, and small intestine) and the same prospective observations are necessary to assess effectiveness of these techniques and outcomes to improve future upper gastrointestinal endoscopy.

Trial objectives This monocenter trial aims to prospectively collect video material, images and data of diagnostic and therapeutic endoscopic procedures and the data of the follow up. The imaging during the endoscopy can be done in white light, narrow-band imaging (NBI), blue-light imaging (BLI), I-scan, linked-color imaging or any other available image enhancement technique, including dye-enhancement with indigo carmine or methylene blue.

The aim of this study is to collect these data prospectively in het UZ Gent. The collected videos, images and data will be used for educational (education and/or training of fellows, publications and postgraduate education) or scientific (discussion amongst peers, scientific meetings and presentations and medical research) purposes by all participating sites.

Endpoint Creation of a large digital database of prospectively collected images, videos and data of endoscopic procedures using any type of imaging technique (e.g., white light endoscopy, video chromoendoscopy, ...) and with consecutive resection of lesions providing a corresponding histology report.

02

Conditions studied

  • Endoscopy

Keywords

  • endoscopy
  • histopathology
  • database
03

In context

Lead sponsor

University Hospital, Ghent is the lead sponsor of 665 studies on the registry; 156 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 4 (80%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients referred for a surveillance, diagnostic or therapeutic endoscopy

Inclusion criteria

  • Age => 18 years
  • Referral for a surveillance, diagnostic or therapeutic endoscopy
  • Digital video material of the endoscopic procedure
  • Digital images of the endoscopic procedure
  • Videos and/or images can be made in white light or any virtual of dye-based enhancement technique
  • Endoscopic procedures performed after IRB approval for this study
  • Material collected in adult patients of all sex or race, including pregnant women

Exclusion criteria

Exclusion Criteria:

  • Age \< 18 years
  • Any contraindication to undergo an endoscopic procedure
  • Patient did not sign informed consent
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
510 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Digital Database of Prospectively collected images, videos and data of endoscopic procedures

    Creation of a large digital database of prospectively collected images, videos and data of endoscopic procedures using any type of imaging technique (e.g., white light endoscopy, video chromoendoscopy, ...) and with consecutive resection of lesions providing a corresponding histology report.

    Time frame: 01/11/2022 - 30/10/2025

07

Study locations

1 of 1 sites recruiting
  • University Hospital Ghent
    Ghent, East Flanders 9000, Belgium
    • Karolien Haenebalcke · Contact
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06467929
Lead sponsor
University Hospital, Ghent
Responsible party
Sponsor
First posted
Jun 21, 2024
Start date
Dec 22, 2022
Primary completion
Oct 30, 2025 (estimated)
Completion
Oct 30, 2025 (estimated)
Last update
Sep 19, 2024

Study contacts

Karolien Haenebalcke
Contact
karolien.haenebalcke@uzgent.be
93321063 ext. +32
David Tate, Doctor
principal investigator · UZ Gent

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion